Craft

LGC

Revenue

£18.6 M

FY, 2022

LGC Summary

Company Summary

Overview
LGC is a life science tools company providing components and solutions for high-growth application areas. It specializes in the genomics, including oligonucleotides, molecular biology reagents, next-generation sequencing (NGS) kits and enzymes, oligo synthesis reagents and instruments, polymerase chain reaction (PCR) reagents and instruments, and sample prep reagents and instruments through LGC Biosearch Technologies. In addition, the company develops nucleic acid therapeutics and nucleic acid-based medicines through LGC Axolabs. LGC serves human healthcare and applied market segments.
Type
Subsidiary
Status
Active
Founded
1842
HQ
Teddington, GB | view all locations
Website
https://www.lgcgroup.com/
Cybersecurity rating
Sectors

Key People

  • Euan O'Sullivan

    Euan O'Sullivan, President and Chief Executive Officer, Director

  • Vivid Sehgal

    Vivid Sehgal, Chief Financial Officer and Director

  • Manjeet Aujla

    Manjeet Aujla, Chief Transformation Officer

  • Julie Cormack

    Julie Cormack, Chief People Officer

Operating MetricsView all

Solutions

6

Jun, 2023

Trademarks

2

Jun, 2023

Industries Served

3

Jun, 2023

LocationsView all

35 locations detected

  • Teddington, England HQ

    United Kingdom

    Queen's Rd

  • Alexandria, MN

    United States

    3600 Minnesota St

  • Lexington, KY

    United States

    1745 Alysheba Way #160

  • Novato, CA

    United States

    51 Digital Dr

  • Petaluma, CA

    United States

    2199 S McDowell Blvd

  • Traverse City, MI

    United States

    1159 Business Park Dr

and 29 others

LGC Financials

Summary Financials

Revenue (FY, 2022)
£18.6M
Net income (FY, 2022)
£86.4M
Cash (FY, 2022)
£32.0K
EBIT (FY, 2022)
£9.6M

Footer menu